GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf6
|
ENSRNOG00000016885 | Kruppel-like factor 6 |
Patz1
|
ENSRNOG00000018709 | POZ (BTB) and AT hook containing zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf6 | rn6_v1_chr17_-_67904674_67904674 | -0.27 | 1.3e-06 | Click! |
Patz1 | rn6_v1_chr14_+_83510640_83510640 | -0.05 | 3.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_20607507 | 78.84 |
ENSRNOT00000000011
|
Cbln1
|
cerebellin 1 precursor |
chr1_-_198454914 | 65.59 |
ENSRNOT00000049044
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr15_+_3936786 | 59.84 |
ENSRNOT00000066163
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma |
chr20_-_48503898 | 53.92 |
ENSRNOT00000073091
|
Wasf1
|
WAS protein family, member 1 |
chr7_-_116607674 | 52.64 |
ENSRNOT00000076014
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr5_+_139783951 | 52.17 |
ENSRNOT00000081333
|
Rims3
|
regulating synaptic membrane exocytosis 3 |
chr10_-_85974644 | 49.24 |
ENSRNOT00000006098
ENSRNOT00000082974 |
Cacnb1
|
calcium voltage-gated channel auxiliary subunit beta 1 |
chr8_-_94564525 | 47.29 |
ENSRNOT00000084437
|
Snap91
|
synaptosomal-associated protein 91 |
chr9_+_73493027 | 45.91 |
ENSRNOT00000074427
ENSRNOT00000089478 |
Unc80
|
unc-80 homolog, NALCN activator |
chr9_+_9961021 | 45.03 |
ENSRNOT00000075767
|
Tubb4a
|
tubulin, beta 4A class IVa |
chrX_-_38196060 | 44.72 |
ENSRNOT00000006741
ENSRNOT00000006438 |
Sh3kbp1
|
SH3 domain-containing kinase-binding protein 1 |
chr10_+_56627411 | 43.92 |
ENSRNOT00000089108
ENSRNOT00000068493 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr9_+_17841410 | 43.38 |
ENSRNOT00000031706
|
Tmem151b
|
transmembrane protein 151B |
chr6_+_144384773 | 41.75 |
ENSRNOT00000006942
|
Ptprn2
|
protein tyrosine phosphatase, receptor type N2 |
chr1_-_220480132 | 40.95 |
ENSRNOT00000027421
|
Cnih2
|
cornichon family AMPA receptor auxiliary protein 2 |
chr7_-_116607408 | 39.77 |
ENSRNOT00000076009
ENSRNOT00000056554 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr10_+_56546710 | 37.77 |
ENSRNOT00000023003
|
Ybx2
|
Y box binding protein 2 |
chr18_+_83471342 | 37.43 |
ENSRNOT00000019384
|
Neto1
|
neuropilin and tolloid like 1 |
chr4_-_71713063 | 37.07 |
ENSRNOT00000059447
|
Fam131b
|
family with sequence similarity 131, member B |
chr10_+_39655455 | 37.05 |
ENSRNOT00000058817
|
Acsl6
|
acyl-CoA synthetase long-chain family member 6 |
chr7_-_136853957 | 36.43 |
ENSRNOT00000008985
|
Nell2
|
neural EGFL like 2 |
chr7_+_70364813 | 36.05 |
ENSRNOT00000084012
ENSRNOT00000031230 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr11_+_83975367 | 35.64 |
ENSRNOT00000058131
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr9_-_28972835 | 35.50 |
ENSRNOT00000086967
ENSRNOT00000079684 |
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr1_+_198383201 | 35.15 |
ENSRNOT00000037405
|
Sez6l2
|
seizure related 6 homolog like 2 |
chr5_-_85123829 | 34.35 |
ENSRNOT00000007578
|
Brinp1
|
BMP/retinoic acid inducible neural specific 1 |
chr6_+_29977797 | 33.73 |
ENSRNOT00000071784
|
Fkbp1b
|
FK506 binding protein 1B |
chr9_+_16612433 | 33.71 |
ENSRNOT00000023979
|
Klhdc3
|
kelch domain containing 3 |
chr1_-_87155118 | 33.45 |
ENSRNOT00000072441
|
AABR07002854.1
|
|
chr1_+_80195532 | 32.87 |
ENSRNOT00000022528
|
Rtn2
|
reticulon 2 |
chr1_+_100297152 | 32.86 |
ENSRNOT00000026100
|
Shank1
|
SH3 and multiple ankyrin repeat domains 1 |
chr10_+_57278307 | 32.86 |
ENSRNOT00000005612
|
Eno3
|
enolase 3 |
chr20_+_12429315 | 31.83 |
ENSRNOT00000001675
|
Pcbp3
|
poly(rC) binding protein 3 |
chr2_+_121165137 | 31.15 |
ENSRNOT00000016236
|
Sox2
|
SRY box 2 |
chr1_+_101161252 | 31.04 |
ENSRNOT00000028064
ENSRNOT00000064184 |
Slc17a7
|
solute carrier family 17 member 7 |
chr1_+_221872220 | 30.88 |
ENSRNOT00000028651
|
Nrxn2
|
neurexin 2 |
chr6_+_127400585 | 30.78 |
ENSRNOT00000087429
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr13_-_98772968 | 30.76 |
ENSRNOT00000057735
|
Stum
|
stum, mechanosensory transduction mediator homolog |
chr1_+_173607101 | 30.64 |
ENSRNOT00000074636
|
Tub
|
tubby bipartite transcription factor |
chr3_+_161425988 | 30.31 |
ENSRNOT00000065184
|
Slc12a5
|
solute carrier family 12 member 5 |
chr15_-_33775109 | 29.78 |
ENSRNOT00000033722
|
Jph4
|
junctophilin 4 |
chr10_-_83332851 | 29.22 |
ENSRNOT00000007133
|
Nxph3
|
neurexophilin 3 |
chr9_+_82596355 | 29.21 |
ENSRNOT00000065076
|
Speg
|
SPEG complex locus |
chr20_+_5535432 | 28.89 |
ENSRNOT00000040859
|
Syngap1
|
synaptic Ras GTPase activating protein 1 |
chr18_+_16650806 | 28.87 |
ENSRNOT00000093679
ENSRNOT00000041961 ENSRNOT00000093140 |
Fhod3
|
formin homology 2 domain containing 3 |
chr7_-_59514939 | 28.68 |
ENSRNOT00000085579
|
Kcnmb4
|
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
chr8_-_23063041 | 28.66 |
ENSRNOT00000018416
|
Elavl3
|
ELAV like RNA binding protein 3 |
chr14_+_108826831 | 28.38 |
ENSRNOT00000083146
ENSRNOT00000009421 |
Bcl11a
|
B-cell CLL/lymphoma 11A |
chr7_-_136853154 | 27.54 |
ENSRNOT00000087376
|
Nell2
|
neural EGFL like 2 |
chr2_-_220101791 | 27.33 |
ENSRNOT00000022905
|
Plppr5
|
phospholipid phosphatase related 5 |
chr16_+_22250470 | 27.17 |
ENSRNOT00000015799
|
Lzts1
|
leucine zipper tumor suppressor 1 |
chrX_-_15707436 | 27.16 |
ENSRNOT00000085907
|
Syp
|
synaptophysin |
chr16_-_5795825 | 27.09 |
ENSRNOT00000048043
|
Cacna2d3
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
chr4_-_180234804 | 26.88 |
ENSRNOT00000070957
|
Bhlhe41
|
basic helix-loop-helix family, member e41 |
chr6_-_27024129 | 26.87 |
ENSRNOT00000012273
|
Dpysl5
|
dihydropyrimidinase-like 5 |
chr18_+_28781349 | 26.83 |
ENSRNOT00000026112
|
Psd2
|
pleckstrin and Sec7 domain containing 2 |
chr18_+_31094965 | 26.77 |
ENSRNOT00000026526
|
Rell2
|
RELT-like 2 |
chr1_+_234252757 | 26.72 |
ENSRNOT00000091814
|
Rorb
|
RAR-related orphan receptor B |
chr2_+_206064394 | 26.33 |
ENSRNOT00000077739
|
Syt6
|
synaptotagmin 6 |
chr3_-_1924827 | 26.30 |
ENSRNOT00000006162
|
Cacna1b
|
calcium voltage-gated channel subunit alpha1 B |
chr13_-_90589466 | 26.17 |
ENSRNOT00000070812
|
Pea15
|
phosphoprotein enriched in astrocytes 15 |
chr6_-_94980004 | 26.14 |
ENSRNOT00000006373
|
Rtn1
|
reticulon 1 |
chr1_+_221792221 | 25.81 |
ENSRNOT00000054828
|
Nrxn2
|
neurexin 2 |
chr7_-_70842405 | 25.80 |
ENSRNOT00000047449
|
Nxph4
|
neurexophilin 4 |
chr7_-_140483693 | 25.30 |
ENSRNOT00000089060
|
Ddn
|
dendrin |
chr8_-_12993651 | 25.21 |
ENSRNOT00000033932
|
Kdm4d
|
lysine demethylase 4D |
chr11_+_86512797 | 24.84 |
ENSRNOT00000051680
|
Gp1bb
|
glycoprotein Ib platelet beta subunit |
chr5_-_109621170 | 24.64 |
ENSRNOT00000093007
|
Elavl2
|
ELAV like RNA binding protein 2 |
chr8_+_62723788 | 24.56 |
ENSRNOT00000010620
|
Sema7a
|
semaphorin 7A (John Milton Hagen blood group) |
chr4_-_157381105 | 24.56 |
ENSRNOT00000021670
|
Gpr162
|
G protein-coupled receptor 162 |
chr19_-_9801942 | 24.35 |
ENSRNOT00000051414
ENSRNOT00000017494 |
Ndrg4
|
NDRG family member 4 |
chr2_+_113984646 | 24.30 |
ENSRNOT00000016799
|
Tnik
|
TRAF2 and NCK interacting kinase |
chr5_+_156876706 | 24.04 |
ENSRNOT00000021864
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr20_+_19318250 | 23.64 |
ENSRNOT00000000299
|
Phyhipl
|
phytanoyl-CoA 2-hydroxylase interacting protein-like |
chr5_-_17061837 | 23.48 |
ENSRNOT00000011892
|
Penk
|
proenkephalin |
chr4_+_56674832 | 23.46 |
ENSRNOT00000060309
|
Ccdc136
|
coiled-coil domain containing 136 |
chr7_+_133400485 | 22.89 |
ENSRNOT00000006219
|
Cntn1
|
contactin 1 |
chr9_+_16862248 | 22.71 |
ENSRNOT00000080104
ENSRNOT00000024824 |
Ttbk1
|
tau tubulin kinase 1 |
chr5_-_101588001 | 22.53 |
ENSRNOT00000016130
|
Psip1
|
PC4 and SFRS1 interacting protein 1 |
chrX_-_123601100 | 22.48 |
ENSRNOT00000092546
ENSRNOT00000092301 |
Sept6
|
septin 6 |
chr1_+_219348721 | 22.46 |
ENSRNOT00000025084
|
Pitpnm1
|
phosphatidylinositol transfer protein, membrane-associated 1 |
chr19_+_25526751 | 22.36 |
ENSRNOT00000083448
|
Cacna1a
|
calcium voltage-gated channel subunit alpha1 A |
chr5_-_144779212 | 22.35 |
ENSRNOT00000016230
|
Ncdn
|
neurochondrin |
chr8_-_130429132 | 22.23 |
ENSRNOT00000026261
|
Hhatl
|
hedgehog acyltransferase-like |
chr1_-_220136470 | 21.91 |
ENSRNOT00000026812
|
Actn3
|
actinin alpha 3 |
chr4_-_155116154 | 21.85 |
ENSRNOT00000020529
|
Phc1
|
polyhomeotic homolog 1 |
chr1_-_222182721 | 21.75 |
ENSRNOT00000078008
|
Tex40
|
testis expressed 40 |
chr13_+_51034256 | 21.66 |
ENSRNOT00000004528
ENSRNOT00000046854 ENSRNOT00000087320 |
Mybph
|
myosin binding protein H |
chr9_+_82674202 | 21.60 |
ENSRNOT00000027208
|
Tmem198
|
transmembrane protein 198 |
chr1_-_64350338 | 21.57 |
ENSRNOT00000078444
|
Cacng8
|
calcium voltage-gated channel auxiliary subunit gamma 8 |
chr16_-_73152921 | 21.43 |
ENSRNOT00000048602
|
Zmat4
|
zinc finger, matrin type 4 |
chr7_-_107009330 | 21.43 |
ENSRNOT00000074573
|
Kcnq3
|
potassium voltage-gated channel subfamily Q member 3 |
chr6_-_99783047 | 21.36 |
ENSRNOT00000009028
|
Sptb
|
spectrin, beta, erythrocytic |
chr1_-_72727112 | 21.35 |
ENSRNOT00000031172
|
Brsk1
|
BR serine/threonine kinase 1 |
chr9_+_82120059 | 21.26 |
ENSRNOT00000057368
|
Cdk5r2
|
cyclin-dependent kinase 5 regulatory subunit 2 |
chr3_+_56861396 | 21.17 |
ENSRNOT00000000008
ENSRNOT00000084375 |
Gad1
|
glutamate decarboxylase 1 |
chr3_-_3476215 | 21.11 |
ENSRNOT00000024352
|
Ubac1
|
UBA domain containing 1 |
chr3_-_105470475 | 20.93 |
ENSRNOT00000011078
|
Gjd2
|
gap junction protein, delta 2 |
chr17_+_10384511 | 20.91 |
ENSRNOT00000024357
|
Sncb
|
synuclein, beta |
chr3_-_66417741 | 20.82 |
ENSRNOT00000007662
|
Neurod1
|
neuronal differentiation 1 |
chr13_+_40300039 | 20.75 |
ENSRNOT00000049137
|
AABR07020786.1
|
|
chr5_-_58019836 | 20.62 |
ENSRNOT00000066977
|
Enho
|
energy homeostasis associated |
chr1_+_211423022 | 20.60 |
ENSRNOT00000029587
|
Dpysl4
|
dihydropyrimidinase-like 4 |
chr3_-_151032302 | 20.51 |
ENSRNOT00000025315
|
Ggt7
|
gamma-glutamyltransferase 7 |
chr20_-_1980101 | 20.45 |
ENSRNOT00000084582
ENSRNOT00000085050 ENSRNOT00000082545 ENSRNOT00000088396 |
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr2_+_174542667 | 20.36 |
ENSRNOT00000076793
|
Fstl5
|
follistatin-like 5 |
chr7_+_12043794 | 20.36 |
ENSRNOT00000039813
|
Atp8b3
|
ATPase phospholipid transporting 8B3 |
chr3_-_150062311 | 20.34 |
ENSRNOT00000022115
|
E2f1
|
E2F transcription factor 1 |
chr7_+_78092037 | 20.32 |
ENSRNOT00000050753
|
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr3_+_111545007 | 20.28 |
ENSRNOT00000007247
|
Itpka
|
inositol-trisphosphate 3-kinase A |
chr3_+_41019898 | 20.25 |
ENSRNOT00000007335
|
Kcnj3
|
potassium voltage-gated channel subfamily J member 3 |
chr13_-_51183269 | 20.24 |
ENSRNOT00000039540
|
Ppfia4
|
PTPRF interacting protein alpha 4 |
chr13_+_48607308 | 20.17 |
ENSRNOT00000063882
|
Slc41a1
|
solute carrier family 41 member 1 |
chr13_-_91872954 | 20.07 |
ENSRNOT00000004613
ENSRNOT00000079263 |
Cadm3
|
cell adhesion molecule 3 |
chr4_-_152380184 | 20.05 |
ENSRNOT00000091473
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr3_+_56862691 | 19.92 |
ENSRNOT00000087712
|
Gad1
|
glutamate decarboxylase 1 |
chr5_-_105582375 | 19.81 |
ENSRNOT00000083373
|
Slc24a2
|
solute carrier family 24 member 2 |
chr5_+_147323240 | 19.78 |
ENSRNOT00000047152
|
Fndc5
|
fibronectin type III domain containing 5 |
chr8_+_48422036 | 19.74 |
ENSRNOT00000036051
|
Usp2
|
ubiquitin specific peptidase 2 |
chr4_+_21317695 | 19.72 |
ENSRNOT00000007572
|
Grm3
|
glutamate metabotropic receptor 3 |
chr5_-_101588598 | 19.65 |
ENSRNOT00000082239
|
Psip1
|
PC4 and SFRS1 interacting protein 1 |
chr1_+_266953139 | 19.61 |
ENSRNOT00000054696
|
Neurl1
|
neuralized E3 ubiquitin protein ligase 1 |
chr10_+_67862054 | 19.55 |
ENSRNOT00000031746
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1 |
chr2_-_148050423 | 19.53 |
ENSRNOT00000064506
ENSRNOT00000023469 |
LOC100909840
|
profilin-2-like |
chr1_-_64405149 | 19.43 |
ENSRNOT00000089944
|
Cacng7
|
calcium voltage-gated channel auxiliary subunit gamma 7 |
chr12_+_19599834 | 19.29 |
ENSRNOT00000092039
ENSRNOT00000042006 |
Stag3
|
stromal antigen 3 |
chr12_+_2534212 | 19.16 |
ENSRNOT00000001399
|
Ctxn1
|
cortexin 1 |
chr18_-_38088457 | 18.98 |
ENSRNOT00000077814
|
Jakmip2
|
janus kinase and microtubule interacting protein 2 |
chr10_-_56444847 | 18.89 |
ENSRNOT00000056872
ENSRNOT00000092662 |
Nlgn2
|
neuroligin 2 |
chr8_+_49737798 | 18.82 |
ENSRNOT00000022476
|
Dscaml1
|
DS cell adhesion molecule-like 1 |
chr1_-_94494980 | 18.82 |
ENSRNOT00000020014
|
Ccne1
|
cyclin E1 |
chr9_-_17114177 | 18.66 |
ENSRNOT00000061185
|
Lrrc73
|
leucine rich repeat containing 73 |
chr2_+_189106039 | 18.58 |
ENSRNOT00000028210
|
Ube2q1
|
ubiquitin conjugating enzyme E2 Q1 |
chr11_+_86516390 | 18.57 |
ENSRNOT00000041168
|
Gp1bb
|
glycoprotein Ib platelet beta subunit |
chr2_+_113984824 | 18.29 |
ENSRNOT00000086399
|
Tnik
|
TRAF2 and NCK interacting kinase |
chr8_+_64364741 | 18.21 |
ENSRNOT00000082840
|
Celf6
|
CUGBP, Elav-like family member 6 |
chr17_-_18592750 | 18.12 |
ENSRNOT00000065742
|
Cap2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr13_-_111765944 | 18.12 |
ENSRNOT00000073041
|
Syt14
|
synaptotagmin 14 |
chr17_+_9679628 | 18.07 |
ENSRNOT00000019569
ENSRNOT00000019393 |
Dbn1
|
drebrin 1 |
chr10_+_92191718 | 18.06 |
ENSRNOT00000006764
ENSRNOT00000032941 |
Crhr1
|
corticotropin releasing hormone receptor 1 |
chr10_-_31419235 | 17.99 |
ENSRNOT00000059496
|
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr9_+_99998275 | 17.99 |
ENSRNOT00000074395
|
Gpc1
|
glypican 1 |
chr3_+_148510779 | 17.95 |
ENSRNOT00000012156
|
Xkr7
|
XK related 7 |
chr10_-_108691367 | 17.90 |
ENSRNOT00000005067
|
Nptx1
|
neuronal pentraxin 1 |
chr8_+_22947152 | 17.88 |
ENSRNOT00000016790
|
Plppr2
|
phospholipid phosphatase related 2 |
chr20_-_1984737 | 17.87 |
ENSRNOT00000040232
ENSRNOT00000051634 ENSRNOT00000079445 |
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr7_+_130431213 | 17.80 |
ENSRNOT00000055792
|
Mapk8ip2
|
mitogen-activated protein kinase 8 interacting protein 2 |
chr2_+_206064179 | 17.74 |
ENSRNOT00000025953
|
Syt6
|
synaptotagmin 6 |
chr11_-_83905889 | 17.70 |
ENSRNOT00000075606
|
Fam131a
|
family with sequence similarity 131, member A |
chr5_+_58393603 | 17.68 |
ENSRNOT00000080082
|
Dnajb5
|
DnaJ heat shock protein family (Hsp40) member B5 |
chr11_-_82884660 | 17.67 |
ENSRNOT00000073526
|
LOC100912498
|
protein FAM131A-like |
chr18_+_56193978 | 17.62 |
ENSRNOT00000041533
ENSRNOT00000080177 |
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr1_-_81946714 | 17.47 |
ENSRNOT00000027578
|
Grik5
|
glutamate ionotropic receptor kainate type subunit 5 |
chr1_-_215836641 | 17.46 |
ENSRNOT00000080246
|
Igf2
|
insulin-like growth factor 2 |
chr2_+_34186091 | 17.46 |
ENSRNOT00000016129
|
Sgtb
|
small glutamine rich tetratricopeptide repeat containing beta |
chr1_-_88112683 | 17.44 |
ENSRNOT00000090615
|
Spred3
|
sprouty-related, EVH1 domain containing 3 |
chr10_-_14056169 | 17.42 |
ENSRNOT00000017833
|
Syngr3
|
synaptogyrin 3 |
chr9_+_38297322 | 17.41 |
ENSRNOT00000078157
ENSRNOT00000088824 |
Bend6
|
BEN domain containing 6 |
chrX_-_152641679 | 17.40 |
ENSRNOT00000080277
|
Gabra3
|
gamma-aminobutyric acid type A receptor alpha3 subunit |
chr1_-_84491466 | 17.36 |
ENSRNOT00000034609
|
Map3k10
|
mitogen activated protein kinase kinase kinase 10 |
chr1_+_101783621 | 17.29 |
ENSRNOT00000067679
|
Lmtk3
|
lemur tyrosine kinase 3 |
chr19_-_11669578 | 17.13 |
ENSRNOT00000026373
|
Gnao1
|
G protein subunit alpha o1 |
chr1_-_165680176 | 17.10 |
ENSRNOT00000025245
ENSRNOT00000082697 |
Plekhb1
|
pleckstrin homology domain containing B1 |
chr3_+_168345152 | 17.07 |
ENSRNOT00000017654
|
Dok5
|
docking protein 5 |
chr11_+_75905443 | 17.04 |
ENSRNOT00000002650
|
Fgf12
|
fibroblast growth factor 12 |
chr1_+_221801524 | 16.97 |
ENSRNOT00000031227
|
Nrxn2
|
neurexin 2 |
chr15_-_28696122 | 16.89 |
ENSRNOT00000060467
|
Rab2b
|
RAB2B, member RAS oncogene family |
chr7_+_123510804 | 16.83 |
ENSRNOT00000010491
|
Sept3
|
septin 3 |
chr7_-_70552897 | 16.83 |
ENSRNOT00000080594
|
Kif5a
|
kinesin family member 5A |
chr14_-_78902063 | 16.82 |
ENSRNOT00000088469
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr1_-_90685257 | 16.81 |
ENSRNOT00000037700
|
Chst8
|
carbohydrate sulfotransferase 8 |
chr3_+_113818872 | 16.79 |
ENSRNOT00000044158
|
Casc4
|
cancer susceptibility candidate 4 |
chr8_-_117382715 | 16.78 |
ENSRNOT00000027466
|
P4htm
|
prolyl 4-hydroxylase, transmembrane |
chr8_+_71216178 | 16.78 |
ENSRNOT00000021372
|
Oaz2
|
ornithine decarboxylase antizyme 2 |
chr12_-_30566032 | 16.68 |
ENSRNOT00000093378
|
Gbas
|
glioblastoma amplified sequence |
chr10_+_89376530 | 16.68 |
ENSRNOT00000028089
|
Rnd2
|
Rho family GTPase 2 |
chr2_+_239415046 | 16.66 |
ENSRNOT00000072196
|
Cxxc4
|
CXXC finger protein 4 |
chr1_+_241594565 | 16.55 |
ENSRNOT00000020123
|
Apba1
|
amyloid beta precursor protein binding family A member 1 |
chr2_-_147959567 | 16.52 |
ENSRNOT00000063986
|
LOC100909840
|
profilin-2-like |
chr3_+_177225737 | 16.51 |
ENSRNOT00000045845
|
Oprl1
|
opioid related nociceptin receptor 1 |
chr5_+_58393233 | 16.49 |
ENSRNOT00000000142
|
Dnajb5
|
DnaJ heat shock protein family (Hsp40) member B5 |
chr9_+_117538346 | 16.41 |
ENSRNOT00000022849
|
Epb41l3
|
erythrocyte membrane protein band 4.1-like 3 |
chr13_+_52976507 | 16.38 |
ENSRNOT00000090599
ENSRNOT00000011324 |
Kif21b
|
kinesin family member 21B |
chr3_-_143063983 | 16.37 |
ENSRNOT00000006329
|
Napb
|
NSF attachment protein beta |
chr5_-_133959447 | 16.36 |
ENSRNOT00000011985
|
Cyp4x1
|
cytochrome P450, family 4, subfamily x, polypeptide 1 |
chr1_+_105349069 | 16.25 |
ENSRNOT00000056030
|
Nell1
|
neural EGFL like 1 |
chr5_+_43603043 | 16.19 |
ENSRNOT00000009899
|
Epha7
|
Eph receptor A7 |
chr10_+_13854339 | 16.17 |
ENSRNOT00000004486
ENSRNOT00000043951 |
Caskin1
|
CASK interacting protein 1 |
chr6_+_64297888 | 16.15 |
ENSRNOT00000050222
ENSRNOT00000083088 ENSRNOT00000093147 |
Nrcam
|
neuronal cell adhesion molecule |
chrX_-_32355296 | 16.14 |
ENSRNOT00000081652
ENSRNOT00000065075 |
Ap1s2
|
adaptor-related protein complex 1, sigma 2 subunit |
chr1_+_199196059 | 16.11 |
ENSRNOT00000090428
|
Fbxl19
|
F-box and leucine-rich repeat protein 19 |
chr8_-_58542844 | 16.07 |
ENSRNOT00000012041
|
Elmod1
|
ELMO domain containing 1 |
chr3_-_11885311 | 16.06 |
ENSRNOT00000021189
ENSRNOT00000021178 |
Stxbp1
|
syntaxin binding protein 1 |
chr10_-_109224370 | 16.05 |
ENSRNOT00000005839
|
Aatk
|
apoptosis-associated tyrosine kinase |
chr3_-_150064438 | 15.98 |
ENSRNOT00000086933
|
E2f1
|
E2F transcription factor 1 |
chr19_-_26053762 | 15.98 |
ENSRNOT00000004646
|
MAST1
|
microtubule associated serine/threonine kinase 1 |
chr1_-_197590277 | 15.93 |
ENSRNOT00000022502
ENSRNOT00000043433 |
Xpo6
|
exportin 6 |
chr5_-_40237591 | 15.72 |
ENSRNOT00000011393
|
Fut9
|
fucosyltransferase 9 |
chr6_+_44009872 | 15.68 |
ENSRNOT00000082657
|
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr9_-_15306465 | 15.66 |
ENSRNOT00000019404
|
Frs3
|
fibroblast growth factor receptor substrate 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.4 | 92.6 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
15.0 | 45.1 | GO:0031632 | positive regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031632) |
13.8 | 41.5 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
12.5 | 37.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
12.5 | 37.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
12.3 | 37.0 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
12.3 | 61.5 | GO:0098970 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
11.0 | 65.7 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
10.7 | 32.0 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
10.2 | 40.8 | GO:0021586 | pons maturation(GO:0021586) |
9.2 | 46.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
9.0 | 71.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
8.9 | 44.4 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
8.8 | 44.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
8.7 | 17.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
8.4 | 25.2 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
8.4 | 25.1 | GO:0060082 | eye blink reflex(GO:0060082) |
8.2 | 41.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
8.2 | 32.9 | GO:0050893 | sensory processing(GO:0050893) |
8.1 | 24.3 | GO:0050883 | medulla oblongata development(GO:0021550) musculoskeletal movement, spinal reflex action(GO:0050883) |
8.0 | 24.1 | GO:0021905 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
7.3 | 29.4 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
7.3 | 21.9 | GO:0033123 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) positive regulation of purine nucleotide catabolic process(GO:0033123) |
7.3 | 21.9 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
7.1 | 85.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
6.8 | 13.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
6.8 | 47.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
6.8 | 33.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
6.7 | 26.7 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
6.5 | 39.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
6.4 | 12.9 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
6.3 | 69.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
6.3 | 25.1 | GO:0044211 | CTP salvage(GO:0044211) |
6.1 | 30.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
6.1 | 18.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
6.0 | 6.0 | GO:0008355 | olfactory learning(GO:0008355) |
5.7 | 28.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
5.6 | 33.9 | GO:0021759 | globus pallidus development(GO:0021759) |
5.6 | 16.8 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
5.6 | 16.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
5.5 | 27.6 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
5.4 | 10.9 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
5.4 | 27.1 | GO:0060023 | soft palate development(GO:0060023) |
5.3 | 10.5 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) |
5.1 | 30.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
5.0 | 10.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
5.0 | 14.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
5.0 | 5.0 | GO:0043578 | nuclear matrix organization(GO:0043578) |
4.9 | 39.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
4.9 | 9.8 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
4.9 | 39.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
4.7 | 85.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
4.7 | 23.7 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
4.7 | 14.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
4.6 | 41.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
4.6 | 59.6 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
4.5 | 157.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
4.5 | 4.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
4.5 | 8.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
4.5 | 8.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
4.5 | 26.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
4.4 | 22.2 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
4.4 | 8.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
4.4 | 13.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
4.4 | 48.0 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
4.3 | 47.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
4.3 | 21.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
4.3 | 12.8 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
4.2 | 4.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
4.2 | 12.6 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
4.2 | 33.4 | GO:0006751 | glutathione catabolic process(GO:0006751) |
4.2 | 12.5 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
4.2 | 12.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
4.1 | 16.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
4.1 | 12.2 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
4.1 | 8.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
4.0 | 16.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
4.0 | 19.9 | GO:0061743 | motor learning(GO:0061743) |
3.9 | 7.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
3.9 | 27.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
3.9 | 7.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
3.9 | 15.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
3.9 | 11.7 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
3.9 | 109.4 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
3.9 | 15.6 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
3.9 | 11.6 | GO:0030576 | Cajal body organization(GO:0030576) |
3.8 | 15.4 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
3.7 | 14.9 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) regulation of connective tissue replacement(GO:1905203) |
3.7 | 22.1 | GO:0010045 | response to nickel cation(GO:0010045) |
3.7 | 62.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
3.6 | 10.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
3.6 | 17.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
3.6 | 7.1 | GO:0099543 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
3.6 | 46.3 | GO:0007614 | short-term memory(GO:0007614) |
3.6 | 10.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.5 | 10.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
3.5 | 10.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
3.5 | 10.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
3.4 | 17.0 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
3.4 | 10.1 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
3.4 | 20.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
3.4 | 13.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
3.3 | 46.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
3.3 | 13.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.3 | 22.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.3 | 13.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
3.2 | 12.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
3.1 | 12.5 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
3.0 | 12.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.0 | 33.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
2.9 | 26.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
2.9 | 14.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
2.9 | 29.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
2.9 | 26.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
2.9 | 8.6 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
2.8 | 8.5 | GO:2000688 | positive regulation of rubidium ion transport(GO:2000682) positive regulation of rubidium ion transmembrane transporter activity(GO:2000688) |
2.8 | 8.4 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
2.8 | 11.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
2.8 | 2.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
2.8 | 8.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
2.7 | 19.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
2.7 | 18.6 | GO:0070459 | prolactin secretion(GO:0070459) |
2.6 | 18.2 | GO:0071625 | vocalization behavior(GO:0071625) |
2.6 | 15.5 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
2.6 | 15.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.6 | 33.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
2.6 | 35.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
2.5 | 20.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.5 | 27.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
2.5 | 9.9 | GO:0033292 | T-tubule organization(GO:0033292) |
2.5 | 19.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.5 | 2.5 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
2.5 | 32.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
2.5 | 7.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
2.5 | 9.8 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
2.4 | 49.0 | GO:0060074 | synapse maturation(GO:0060074) |
2.4 | 51.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
2.4 | 4.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
2.4 | 17.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
2.4 | 7.2 | GO:0072054 | chemoattraction of axon(GO:0061642) renal outer medulla development(GO:0072054) |
2.4 | 9.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
2.4 | 14.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
2.4 | 2.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
2.3 | 28.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
2.3 | 11.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
2.3 | 7.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
2.3 | 6.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
2.3 | 13.8 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
2.3 | 36.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
2.3 | 4.6 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
2.3 | 9.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
2.3 | 6.8 | GO:0006435 | prolyl-tRNA aminoacylation(GO:0006433) threonyl-tRNA aminoacylation(GO:0006435) |
2.3 | 6.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.2 | 33.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
2.2 | 11.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
2.2 | 24.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
2.2 | 20.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
2.2 | 4.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
2.2 | 8.8 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
2.2 | 4.3 | GO:0090427 | activation of meiosis(GO:0090427) |
2.1 | 6.4 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
2.1 | 12.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
2.0 | 8.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.0 | 2.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
2.0 | 8.1 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
2.0 | 8.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
2.0 | 12.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
2.0 | 7.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
2.0 | 9.9 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.0 | 5.9 | GO:0006083 | acetate metabolic process(GO:0006083) propionate metabolic process(GO:0019541) |
1.9 | 13.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.9 | 34.7 | GO:0001675 | acrosome assembly(GO:0001675) |
1.9 | 7.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.9 | 38.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
1.9 | 7.7 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.9 | 3.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.9 | 11.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.9 | 16.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
1.8 | 9.2 | GO:2000327 | positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.8 | 11.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.8 | 5.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
1.8 | 21.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.8 | 5.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.8 | 86.0 | GO:0021762 | substantia nigra development(GO:0021762) |
1.8 | 7.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
1.8 | 17.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.8 | 5.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.8 | 8.8 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.8 | 24.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
1.7 | 5.2 | GO:0018343 | protein farnesylation(GO:0018343) |
1.7 | 12.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.7 | 5.1 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
1.7 | 5.1 | GO:0042441 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
1.7 | 13.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.7 | 8.3 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
1.7 | 8.3 | GO:0061709 | reticulophagy(GO:0061709) |
1.6 | 21.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
1.6 | 22.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
1.6 | 9.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.6 | 17.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.6 | 4.7 | GO:0010265 | SCF complex assembly(GO:0010265) |
1.6 | 4.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.6 | 39.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.6 | 9.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
1.6 | 4.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.6 | 4.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
1.5 | 13.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.5 | 9.2 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.5 | 3.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.5 | 28.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.5 | 22.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.5 | 6.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.5 | 6.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
1.5 | 4.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.5 | 4.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.5 | 1.5 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
1.5 | 7.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.5 | 37.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
1.4 | 7.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.4 | 7.2 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
1.4 | 21.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.4 | 4.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) fatty-acyl-CoA catabolic process(GO:0036115) |
1.4 | 9.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.4 | 4.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
1.4 | 7.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.4 | 2.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.4 | 14.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.4 | 2.8 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
1.4 | 4.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
1.4 | 9.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.4 | 1.4 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) |
1.4 | 16.4 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
1.4 | 12.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.4 | 12.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.4 | 9.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.3 | 2.7 | GO:0036394 | amylase secretion(GO:0036394) |
1.3 | 4.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.3 | 29.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.3 | 4.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
1.3 | 2.7 | GO:0072003 | kidney rudiment formation(GO:0072003) |
1.3 | 4.0 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
1.3 | 11.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.3 | 3.9 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.3 | 6.5 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
1.3 | 2.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.3 | 28.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.3 | 6.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.2 | 18.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.2 | 3.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
1.2 | 4.9 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
1.2 | 12.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.2 | 3.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.2 | 3.5 | GO:0050955 | thermoception(GO:0050955) |
1.2 | 35.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
1.1 | 6.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.1 | 4.6 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
1.1 | 2.3 | GO:0061197 | fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
1.1 | 10.2 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.1 | 2.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
1.1 | 5.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.1 | 4.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.1 | 5.6 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.1 | 4.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.1 | 4.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
1.1 | 12.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.1 | 9.7 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.1 | 27.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
1.1 | 3.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 18.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.0 | 2.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.0 | 11.4 | GO:0000338 | protein deneddylation(GO:0000338) |
1.0 | 12.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.0 | 8.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
1.0 | 4.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
1.0 | 3.1 | GO:0036337 | Fas signaling pathway(GO:0036337) |
1.0 | 4.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.0 | 4.1 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
1.0 | 3.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
1.0 | 28.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
1.0 | 7.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.0 | 10.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.0 | 26.9 | GO:0019835 | cytolysis(GO:0019835) |
1.0 | 30.9 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
1.0 | 15.8 | GO:0009629 | response to gravity(GO:0009629) |
1.0 | 5.9 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
1.0 | 15.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.0 | 2.0 | GO:1904373 | response to kainic acid(GO:1904373) |
1.0 | 5.7 | GO:0090383 | phagosome acidification(GO:0090383) |
1.0 | 3.8 | GO:0021794 | thalamus development(GO:0021794) |
0.9 | 2.8 | GO:1902103 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
0.9 | 6.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.9 | 1.9 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.9 | 2.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.9 | 2.8 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.9 | 4.7 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.9 | 1.9 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.9 | 2.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.9 | 7.4 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.9 | 4.5 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.9 | 8.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.9 | 0.9 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) |
0.9 | 2.6 | GO:0090247 | cell motility involved in somitogenic axis elongation(GO:0090247) regulation of cell motility involved in somitogenic axis elongation(GO:0090249) |
0.9 | 3.4 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.8 | 7.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.8 | 2.5 | GO:0007315 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.8 | 1.7 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.8 | 2.5 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.8 | 2.5 | GO:1903774 | ubiquitin-dependent endocytosis(GO:0070086) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.8 | 4.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.8 | 15.6 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.8 | 1.6 | GO:0045869 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.8 | 1.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.8 | 28.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.8 | 4.9 | GO:0001554 | luteolysis(GO:0001554) |
0.8 | 7.3 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.8 | 0.8 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.8 | 4.0 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.8 | 8.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.8 | 3.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.8 | 7.2 | GO:0060068 | vagina development(GO:0060068) |
0.8 | 2.4 | GO:0051977 | lysophospholipid transport(GO:0051977) |
0.8 | 6.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.8 | 5.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.8 | 3.1 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.8 | 3.9 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.8 | 6.2 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.8 | 17.7 | GO:0051693 | actin filament capping(GO:0051693) |
0.8 | 5.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 1.5 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
0.7 | 0.7 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.7 | 2.9 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.7 | 4.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.7 | 29.0 | GO:0048599 | oocyte development(GO:0048599) |
0.7 | 1.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.7 | 7.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.7 | 5.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.7 | 10.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.7 | 84.4 | GO:0048167 | regulation of synaptic plasticity(GO:0048167) |
0.7 | 2.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.7 | 2.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.7 | 2.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.7 | 10.0 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.7 | 4.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 13.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.7 | 1.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.7 | 2.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 1.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.6 | 1.9 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.6 | 5.2 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.6 | 5.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.6 | 1.3 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.6 | 8.9 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.6 | 1.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.6 | 5.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.6 | 2.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.6 | 18.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.6 | 1.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.6 | 2.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 3.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.6 | 4.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.6 | 3.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 4.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.6 | 1.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.6 | 8.2 | GO:0036065 | fucosylation(GO:0036065) |
0.6 | 2.9 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.6 | 2.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 16.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.6 | 36.9 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.6 | 10.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.6 | 11.3 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.6 | 11.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.6 | 10.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.6 | 0.6 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.6 | 6.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.6 | 2.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.6 | 4.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 8.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.5 | 1.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.5 | 4.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.5 | 16.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 3.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 9.9 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.5 | 20.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.5 | 6.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.5 | 18.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.5 | 2.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.5 | 1.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 2.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 20.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 3.0 | GO:0007512 | adult heart development(GO:0007512) |
0.5 | 4.9 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.5 | 3.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 14.2 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.5 | 1.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 5.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 6.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.5 | 1.9 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.5 | 4.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.5 | 15.6 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.5 | 0.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.5 | 10.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.5 | 2.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 4.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.5 | 3.2 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.5 | 1.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.5 | 3.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 2.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.4 | 8.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 8.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.4 | 5.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 6.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 8.9 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.4 | 6.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 2.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 3.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.4 | 6.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 3.2 | GO:0001502 | cartilage condensation(GO:0001502) |
0.4 | 7.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 1.2 | GO:0031223 | auditory behavior(GO:0031223) |
0.4 | 27.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.4 | 5.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.4 | 1.9 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.4 | 6.9 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.4 | 4.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.4 | 2.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 0.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 1.4 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.4 | 1.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.3 | 3.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.3 | 6.7 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 0.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 1.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.3 | 3.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 3.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 4.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.9 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) peptidyl-glycine modification(GO:0018201) |
0.3 | 0.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.3 | 3.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 2.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 4.8 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.3 | 1.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.3 | 3.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.3 | 1.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.8 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.3 | 2.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 0.5 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 4.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 3.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 5.5 | GO:0051293 | establishment of spindle localization(GO:0051293) |
0.3 | 3.6 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.3 | 2.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 4.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 1.0 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.3 | 0.8 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.3 | 0.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 1.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 5.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 1.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.9 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.2 | 1.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 1.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 1.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 2.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 3.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.2 | 3.5 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.2 | 2.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.4 | GO:1901069 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 1.3 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.2 | 21.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.2 | 2.5 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 4.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 12.1 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 1.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.6 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 3.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.2 | 0.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 1.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 2.9 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 6.5 | GO:0048747 | muscle fiber development(GO:0048747) |
0.2 | 1.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 4.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.2 | 2.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 5.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 3.6 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.2 | 3.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 7.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 2.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 2.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.2 | 3.2 | GO:0097480 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.2 | 0.8 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.7 | GO:0019046 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.2 | 1.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 7.8 | GO:0034502 | protein localization to chromosome(GO:0034502) |
0.2 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 4.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 17.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.2 | 4.9 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 4.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 2.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 1.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 1.2 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 4.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.6 | GO:1901073 | glucosamine-containing compound biosynthetic process(GO:1901073) |
0.1 | 5.2 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.1 | 1.6 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.1 | 4.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 5.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 1.9 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 17.5 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 1.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 14.3 | GO:0099536 | synaptic signaling(GO:0099536) |
0.1 | 2.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 4.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 4.5 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.6 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.1 | 1.2 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.1 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 2.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 2.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 1.7 | GO:0010573 | vascular endothelial growth factor production(GO:0010573) |
0.1 | 1.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.5 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 1.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.8 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.7 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.5 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.8 | 16.8 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
15.8 | 47.3 | GO:0098833 | presynaptic endosome(GO:0098830) presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
13.6 | 40.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
12.8 | 38.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
12.2 | 12.2 | GO:0044301 | climbing fiber(GO:0044301) |
9.7 | 97.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
9.7 | 29.0 | GO:0032173 | septin collar(GO:0032173) |
8.7 | 26.0 | GO:0090534 | longitudinal sarcoplasmic reticulum(GO:0014801) calcium ion-transporting ATPase complex(GO:0090534) |
8.5 | 25.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
7.5 | 45.0 | GO:0033269 | internode region of axon(GO:0033269) |
6.4 | 19.3 | GO:0000802 | transverse filament(GO:0000802) |
6.0 | 53.9 | GO:0031209 | SCAR complex(GO:0031209) |
5.8 | 51.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
5.6 | 45.1 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
5.6 | 33.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
5.6 | 16.7 | GO:0005592 | collagen type XI trimer(GO:0005592) |
5.5 | 32.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
5.4 | 54.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
5.3 | 21.3 | GO:0045298 | tubulin complex(GO:0045298) |
5.0 | 124.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
4.9 | 217.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
4.5 | 18.1 | GO:0044308 | axonal spine(GO:0044308) |
4.4 | 17.5 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
4.1 | 12.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
3.9 | 23.5 | GO:0032280 | symmetric synapse(GO:0032280) |
3.8 | 114.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.7 | 18.7 | GO:0072534 | perineuronal net(GO:0072534) |
3.7 | 40.9 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
3.5 | 17.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.5 | 148.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.2 | 28.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
3.2 | 31.7 | GO:0008091 | spectrin(GO:0008091) |
3.1 | 18.9 | GO:0005955 | calcineurin complex(GO:0005955) |
3.1 | 108.4 | GO:0032590 | dendrite membrane(GO:0032590) |
3.0 | 24.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.9 | 5.8 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
2.9 | 8.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.8 | 38.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.7 | 8.2 | GO:1990923 | PET complex(GO:1990923) |
2.7 | 72.8 | GO:0097440 | apical dendrite(GO:0097440) |
2.6 | 33.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.5 | 206.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
2.5 | 7.5 | GO:0034774 | secretory granule lumen(GO:0034774) |
2.4 | 62.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
2.4 | 7.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
2.4 | 35.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.4 | 2.4 | GO:0000805 | X chromosome(GO:0000805) |
2.4 | 7.1 | GO:0005962 | mitochondrial isocitrate dehydrogenase complex (NAD+)(GO:0005962) isocitrate dehydrogenase complex (NAD+)(GO:0045242) |
2.3 | 11.7 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
2.3 | 6.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.3 | 13.7 | GO:0033010 | paranodal junction(GO:0033010) |
2.2 | 26.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
2.1 | 17.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
2.1 | 8.4 | GO:1990005 | granular vesicle(GO:1990005) |
2.1 | 18.9 | GO:0031045 | dense core granule(GO:0031045) |
2.0 | 6.1 | GO:0043511 | inhibin complex(GO:0043511) |
2.0 | 41.5 | GO:0005922 | connexon complex(GO:0005922) |
1.9 | 5.8 | GO:0097444 | spine apparatus(GO:0097444) |
1.9 | 13.5 | GO:0043203 | axon hillock(GO:0043203) |
1.9 | 14.9 | GO:0097452 | GAIT complex(GO:0097452) |
1.9 | 5.6 | GO:0060187 | cell pole(GO:0060187) |
1.8 | 39.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.8 | 10.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.7 | 36.5 | GO:0033268 | node of Ranvier(GO:0033268) |
1.7 | 27.0 | GO:0097449 | astrocyte projection(GO:0097449) |
1.7 | 20.0 | GO:0005796 | Golgi lumen(GO:0005796) |
1.7 | 15.0 | GO:0043194 | axon initial segment(GO:0043194) |
1.7 | 11.6 | GO:0070449 | elongin complex(GO:0070449) |
1.7 | 41.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.7 | 14.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.6 | 80.8 | GO:0043198 | dendritic shaft(GO:0043198) |
1.6 | 8.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.6 | 8.2 | GO:0070695 | FHF complex(GO:0070695) |
1.5 | 40.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.5 | 16.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.5 | 4.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.4 | 9.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.4 | 4.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.4 | 6.8 | GO:0071797 | LUBAC complex(GO:0071797) |
1.4 | 6.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.3 | 42.9 | GO:0044295 | axonal growth cone(GO:0044295) |
1.3 | 3.9 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
1.3 | 95.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.3 | 7.5 | GO:1990635 | proximal dendrite(GO:1990635) |
1.2 | 3.7 | GO:0071942 | XPC complex(GO:0071942) |
1.2 | 31.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.2 | 290.0 | GO:0098793 | presynapse(GO:0098793) |
1.1 | 16.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
1.1 | 5.6 | GO:0097386 | glial cell projection(GO:0097386) |
1.1 | 11.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.1 | 4.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.1 | 14.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.1 | 3.3 | GO:0032437 | cuticular plate(GO:0032437) |
1.1 | 4.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.1 | 21.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) |
1.1 | 19.4 | GO:0031430 | M band(GO:0031430) |
1.0 | 6.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.0 | 13.5 | GO:0030914 | STAGA complex(GO:0030914) |
1.0 | 12.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.0 | 4.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.0 | 24.0 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
1.0 | 2.9 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.9 | 2.8 | GO:0070421 | DNA ligase III-XRCC1 complex(GO:0070421) |
0.9 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 2.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.9 | 3.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 8.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.9 | 6.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.9 | 19.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.9 | 27.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 4.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 1.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 4.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 2.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.8 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.8 | 101.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 25.5 | GO:0016528 | sarcoplasm(GO:0016528) |
0.8 | 15.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.8 | 4.7 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 3.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.8 | 5.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.7 | 8.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.7 | 20.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.7 | 11.4 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 5.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 10.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.7 | 6.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.7 | 60.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.7 | 4.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 43.5 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.6 | 1.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.6 | 15.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.6 | 21.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.6 | 5.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 4.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.6 | 6.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 1.7 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.6 | 4.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 1.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.6 | 29.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.6 | 55.5 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 1.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 4.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.5 | 4.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 5.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 6.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 4.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 5.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.5 | 4.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 6.7 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 1.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 19.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.4 | 2.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 3.2 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 7.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 2.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 1.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 5.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 1.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 3.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 8.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.3 | 22.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 4.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 20.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 2.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 2.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 3.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 2.5 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 24.8 | GO:0031674 | I band(GO:0031674) |
0.3 | 1.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 2.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 1.9 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 3.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.3 | 8.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 36.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 4.2 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 1.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 3.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 10.0 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 3.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 12.6 | GO:0036126 | sperm flagellum(GO:0036126) |
0.3 | 2.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 7.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 31.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 22.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.7 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 2.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.5 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 3.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 1.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.8 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 3.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 5.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 3.8 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 2.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.7 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.2 | 6.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 13.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 5.9 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 11.9 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.2 | 51.6 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 2.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 7.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 4.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 3.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 2.3 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) CIA complex(GO:0097361) |
0.1 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 7.7 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 8.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 1.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 2.2 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 3.9 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.2 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 7.3 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.0 | 0.4 | GO:0030496 | midbody(GO:0030496) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.8 | 117.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
11.7 | 35.0 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
11.4 | 45.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
9.6 | 38.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
9.3 | 46.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
7.5 | 22.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
7.2 | 50.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
6.8 | 20.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
6.6 | 92.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
6.5 | 32.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
6.3 | 25.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
5.8 | 23.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
5.7 | 28.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
5.6 | 16.9 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
5.6 | 16.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
5.5 | 27.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
5.5 | 32.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
5.5 | 16.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
5.3 | 26.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
5.3 | 21.3 | GO:0099609 | microtubule lateral binding(GO:0099609) |
5.0 | 25.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
5.0 | 25.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
4.9 | 43.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
4.8 | 28.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
4.7 | 42.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
4.7 | 14.0 | GO:0031997 | N-terminal myristoylation domain binding(GO:0031997) calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099567) |
4.5 | 18.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
4.5 | 13.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
4.5 | 75.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.5 | 13.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
4.4 | 30.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
4.3 | 30.4 | GO:0097001 | ceramide binding(GO:0097001) |
4.3 | 21.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
4.3 | 30.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.3 | 4.3 | GO:0099510 | calcium ion binding involved in regulation of cytosolic calcium ion concentration(GO:0099510) |
4.2 | 8.4 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
4.2 | 12.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
4.1 | 12.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
4.1 | 12.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
4.0 | 20.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.9 | 39.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
3.8 | 11.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.8 | 26.9 | GO:0043426 | MRF binding(GO:0043426) |
3.7 | 14.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
3.7 | 14.9 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
3.6 | 32.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.6 | 18.0 | GO:0070052 | collagen V binding(GO:0070052) |
3.6 | 21.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
3.6 | 10.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.5 | 21.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
3.5 | 118.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
3.4 | 20.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
3.4 | 20.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
3.3 | 33.3 | GO:0003680 | AT DNA binding(GO:0003680) |
3.2 | 9.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
3.2 | 35.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
3.2 | 12.9 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
3.2 | 9.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
3.1 | 37.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.0 | 21.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
3.0 | 33.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
3.0 | 35.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.9 | 5.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.9 | 14.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
2.9 | 14.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
2.9 | 11.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
2.9 | 8.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) metallodipeptidase activity(GO:0070573) |
2.9 | 17.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
2.9 | 11.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.8 | 19.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
2.8 | 16.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
2.8 | 8.3 | GO:0009931 | calcium-dependent protein kinase C activity(GO:0004698) calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.7 | 13.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.6 | 7.9 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
2.6 | 15.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
2.6 | 15.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
2.6 | 10.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.5 | 10.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
2.5 | 36.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
2.5 | 7.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
2.4 | 68.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.4 | 7.2 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
2.4 | 9.5 | GO:0019002 | GMP binding(GO:0019002) |
2.4 | 18.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.3 | 11.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.3 | 13.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
2.3 | 11.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.3 | 6.8 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) threonine-tRNA ligase activity(GO:0004829) |
2.2 | 6.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.2 | 8.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.2 | 6.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
2.2 | 10.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.2 | 17.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.2 | 8.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.1 | 8.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
2.1 | 10.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
2.1 | 20.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.1 | 20.9 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.0 | 8.2 | GO:0034584 | piRNA binding(GO:0034584) |
2.0 | 6.1 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
2.0 | 12.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
2.0 | 19.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.0 | 31.4 | GO:0005522 | profilin binding(GO:0005522) |
1.9 | 140.2 | GO:0030276 | clathrin binding(GO:0030276) |
1.9 | 52.4 | GO:0030506 | ankyrin binding(GO:0030506) |
1.9 | 9.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.9 | 27.8 | GO:0035198 | miRNA binding(GO:0035198) |
1.9 | 270.9 | GO:0044325 | ion channel binding(GO:0044325) |
1.8 | 9.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.8 | 28.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
1.8 | 17.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.8 | 17.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.8 | 7.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.8 | 7.0 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.7 | 5.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.7 | 19.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.7 | 12.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.7 | 43.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.7 | 5.0 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
1.6 | 11.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.6 | 31.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.6 | 4.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.6 | 4.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.6 | 95.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.6 | 37.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.5 | 23.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.5 | 44.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.4 | 8.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.4 | 4.3 | GO:0035939 | microsatellite binding(GO:0035939) |
1.4 | 20.2 | GO:0051378 | serotonin binding(GO:0051378) |
1.4 | 8.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.4 | 4.3 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.4 | 15.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.4 | 4.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.4 | 4.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.4 | 5.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
1.4 | 12.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.3 | 26.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.3 | 19.9 | GO:0031005 | filamin binding(GO:0031005) |
1.3 | 14.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.3 | 33.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.3 | 55.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.3 | 1.3 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.2 | 6.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.2 | 6.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.2 | 3.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.2 | 78.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
1.1 | 3.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.1 | 9.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.1 | 14.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.1 | 4.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.1 | 21.5 | GO:0032183 | SUMO binding(GO:0032183) |
1.1 | 12.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.1 | 6.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.0 | 10.4 | GO:0048156 | tau protein binding(GO:0048156) |
1.0 | 9.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.0 | 10.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
1.0 | 5.0 | GO:0043495 | protein anchor(GO:0043495) |
1.0 | 3.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.0 | 7.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.0 | 3.9 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
1.0 | 38.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
1.0 | 8.8 | GO:0008494 | translation activator activity(GO:0008494) |
1.0 | 11.7 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
1.0 | 10.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.0 | 5.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.0 | 14.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.0 | 8.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 26.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.9 | 5.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.9 | 1.8 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.9 | 2.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.9 | 1.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.8 | 9.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.8 | 15.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.8 | 72.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.8 | 3.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 11.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.8 | 4.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.8 | 21.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.8 | 38.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.8 | 2.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.8 | 4.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.8 | 4.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.8 | 4.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.8 | 2.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.7 | 5.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.7 | 2.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 5.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.7 | 2.9 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.7 | 4.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.7 | 23.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 19.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.7 | 14.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.7 | 14.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 16.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.7 | 17.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 12.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 4.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.6 | 1.9 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.6 | 5.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.6 | 2.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.6 | 2.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.6 | 1.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 3.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 4.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.6 | 6.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 7.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 9.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 11.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 8.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.6 | 1.8 | GO:0031208 | POZ domain binding(GO:0031208) |
0.6 | 18.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.6 | 14.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.6 | 3.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 7.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 12.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 1.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 27.0 | GO:0019003 | GDP binding(GO:0019003) |
0.5 | 4.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.5 | 1.6 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
0.5 | 1.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 3.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 4.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 35.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.5 | 1.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.5 | 11.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 2.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.5 | 7.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 2.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 17.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.4 | 10.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 7.9 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 9.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.4 | 3.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 16.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.4 | 77.4 | GO:0008017 | microtubule binding(GO:0008017) |
0.4 | 4.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 3.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 11.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 5.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 4.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 11.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 3.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 4.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 4.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.4 | 4.6 | GO:0016918 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.4 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 5.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 2.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 4.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 1.0 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.3 | 1.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 21.1 | GO:0005267 | potassium channel activity(GO:0005267) |
0.3 | 3.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 3.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 5.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 6.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 1.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.9 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.3 | 3.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.3 | 3.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 4.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 1.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 9.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 5.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 2.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.7 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 32.6 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 5.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 5.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 4.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 6.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 30.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 14.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 85.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 5.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 1.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 1.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 3.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 6.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 42.2 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 8.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 5.8 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 2.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.9 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 8.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 2.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 10.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 4.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 22.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 1.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 5.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 1.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 1.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 10.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
4.0 | 102.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
3.0 | 36.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.6 | 70.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
2.5 | 43.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.4 | 81.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
2.3 | 107.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.4 | 6.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.3 | 34.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.1 | 9.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.0 | 37.0 | PID RAS PATHWAY | Regulation of Ras family activation |
1.0 | 26.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.0 | 8.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.9 | 20.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.9 | 38.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.9 | 40.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.9 | 9.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.7 | 2.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.6 | 12.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 4.9 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 8.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 6.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 26.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.5 | 4.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 5.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 11.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 8.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 12.6 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 14.9 | PID ATM PATHWAY | ATM pathway |
0.4 | 15.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 8.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 14.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 3.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 7.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 11.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 5.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 1.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 7.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 4.2 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 31.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 50.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
8.6 | 17.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
5.0 | 70.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
4.0 | 72.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
3.7 | 66.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.3 | 73.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
3.1 | 49.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.9 | 34.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.7 | 41.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.7 | 43.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.6 | 132.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.4 | 4.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
2.3 | 41.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
2.3 | 34.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.2 | 51.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.2 | 13.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
2.2 | 37.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.1 | 16.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.1 | 37.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.8 | 57.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.7 | 39.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.7 | 20.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.6 | 49.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.6 | 9.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.6 | 9.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.5 | 36.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.4 | 20.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.4 | 59.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.4 | 21.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.4 | 28.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
1.3 | 20.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.3 | 29.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.3 | 35.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.2 | 47.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.2 | 6.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.2 | 20.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.2 | 9.3 | REACTOME OPSINS | Genes involved in Opsins |
1.1 | 34.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.1 | 5.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.1 | 4.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
1.0 | 26.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.0 | 16.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.0 | 17.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.0 | 25.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.0 | 18.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.9 | 7.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.9 | 10.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.8 | 10.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 12.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.7 | 10.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 5.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 11.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.7 | 17.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 8.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.7 | 59.5 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.7 | 5.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 11.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 26.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.6 | 5.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 11.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 2.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 6.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.6 | 5.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.6 | 24.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 4.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.6 | 42.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 3.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 9.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 20.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 8.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 7.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.5 | 10.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 10.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 6.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 7.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 39.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.4 | 4.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 52.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 2.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.4 | 4.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 18.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 6.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 15.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 8.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 7.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 5.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 7.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 5.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 3.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 6.7 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 4.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 9.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 1.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 3.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 9.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 4.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 3.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 4.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 2.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 9.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 1.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |